March 19, 2008 08:00 ET

Sunwin International Neutraceuticals Reports Fiscal Third Quarter Results for 2008

Revenue and Earnings Increase Substantially From Same Period in 2007

QUFU, CHINA--(Marketwire - March 19, 2008) - Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie Stevia in China, today announced its third quarter results for fiscal 2008 ended January 31, 2008. The Company reported revenues of approximately $6.61 million and net income of $632,946 as compared to revenues of approximately $3.79 million and net income of $73,942 for the same period in 2007. Revenues for the first nine months of 2008 were $16,513,913, up over 42% from the $11,562,948 recorded in the same period in 2007. Net income increased by over 50% in the first nine months of 2008 reaching $1,074,563, up from 484,838 in 2007.

Overall performance at Sunwin increased sequentially and quarter over quarter in all major categories including veterinary medicine sales, Chinese medicine sales as well as sales of bulk Stevia. Management believes the measures taken in 2007 to expand capacity and develop new veterinary and Chinese medicine products have begun to yield increased sales and earnings in this quarter and will continue to build in the coming quarters. The company has continued to invest in its OnlySweet branding campaign through its Sunwin USA subsidiary and believes that the continued exposure of the brand in major chains will benefit Sunwin if and when Stevia receives approval for use as a sweetener or food additive in the U.S. Worldwide demand for Stevia continues to increase and management believes Sunwin is well positioned to see continued growth in Stevia sales.

Laiwang Zhang, President and Chairman of Sunwin International Neutraceuticals, commented, "In the third quarter we are beginning to see the fruits of our investment in production and branding of our Stevia products as well as the introduction of new veterinary medicines and feeds. We are continuing our efforts to expand all areas of operation and remain very optimistic about our Sunwin USA subsidiary and our OnlySweet product line in North America. As we head into the last quarter of 2008, management believes that Sunwin is positioned to experience continued growth as well as record results in 2009."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals (OTCBB: SUWN) engages in the areas of essential traditional Chinese medicine, zero calorie natural sweeteners (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. For more info about Sunwin, please visit http://www.sunwin.biz.

About OnlySweet™

OnlySweet™ is a proprietary product blended with Stevioside (Stevia), an all natural, zero calorie, naturally sweet dietary supplement, extracted from the leaves of the Stevia Rebaudiana plant. OnlySweet™ is blended and packaged in the United States, and is distributed by Sunwin USA, Inc. in over 3500 grocery stores in the United States. Stevia is used as a food additive in a wide variety of products, such as beverages, pastries, dairy products, confections and medicinal products in Japan, China, Malaysia, Israel, South Korea, Brazil and other countries. In the United States, OnlySweet™ is a dietary supplement sold in boxes of 100 and 200 packets. It has zero calories and does not significantly alter blood sugar levels. OnlySweet™ is unique because its Stevia only comes directly from Sunwin International Neutraceuticals (OTCBB: SUWN), one of the world's largest Stevia manufacturers, assuring consistency and purity.

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the Company's operations, financial performance and, condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The Company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products, pricing and new technology; changes in consumer preferences and tastes; and effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production, and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.